anti inflammatory drugs

Canakinumab      

Select            
Trial Studied trt Control trt patientstagsROB Trial resultAll cause deathSerious infection

percutaneous coronary intervention  

pexelizumab  
APEX-AMI, 2007          NCTpexelizumabplaceboLow risk of bias negative4%-10%